• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 03, 2019 at 12:22: AM
via Japan’s Astellas Pharma Inc (4503.T) has agreed to buy Audentes Therapeutics Inc (BOLD.O) for about $3 billion in cash as it seeks to make genetic medicines a key area of growth.

article source
 




Top Bottom
Back
Quote